163 related articles for article (PubMed ID: 20803876)
1. Computed tomography study of the effect of orlistat on visceral adipose tissue volume in obese subjects.
Dicker D; Herskovitz P; Katz M; Atar E; Bachar GN
Isr Med Assoc J; 2010 Apr; 12(4):199-202. PubMed ID: 20803876
[TBL] [Abstract][Full Text] [Related]
2. Orlistat 60 mg reduces visceral adipose tissue: a 24-week randomized, placebo-controlled, multicenter trial.
Smith SR; Stenlof KS; Greenway FL; McHutchison J; Schwartz SM; Dev VB; Berk ES; Kapikian R
Obesity (Silver Spring); 2011 Sep; 19(9):1796-803. PubMed ID: 21720429
[TBL] [Abstract][Full Text] [Related]
3. [Pharmacological therapy of obesity].
Pagotto U; Vanuzzo D; Vicennati V; Pasquali R
G Ital Cardiol (Rome); 2008 Apr; 9(4 Suppl 1):83S-93S. PubMed ID: 18773755
[TBL] [Abstract][Full Text] [Related]
4. Modification of abdominal fat distribution after aromatase inhibitor therapy in breast cancer patients visualized using 3-D computed tomography volumetry.
Battisti S; Guida FM; Coppa F; Vaccaro DM; Santini D; Tonini G; Zobel BB; Semelka RC
Clin Breast Cancer; 2014 Oct; 14(5):365-70. PubMed ID: 24850544
[TBL] [Abstract][Full Text] [Related]
5. X-PERT: weight reduction with orlistat in obese subjects receiving a mildly or moderately reduced-energy diet: early response to treatment predicts weight maintenance.
Toplak H; Ziegler O; Keller U; Hamann A; Godin C; Wittert G; Zanella MT; Zúñiga-Guajardo S; Van Gaal L
Diabetes Obes Metab; 2005 Nov; 7(6):699-708. PubMed ID: 16219013
[TBL] [Abstract][Full Text] [Related]
6. Metabolic Activity in the Visceral and Subcutaneous Adipose Tissues by FDG-PET/CT in Obese Patients.
Monteiro AM; Ferreira G; Duarte H
Acta Med Port; 2017 Nov; 30(11):813-817. PubMed ID: 29279074
[TBL] [Abstract][Full Text] [Related]
7. It's not only the overweight: it's the visceral fat.
Levy Y
Isr Med Assoc J; 2010 Apr; 12(4):231-2. PubMed ID: 20803884
[No Abstract] [Full Text] [Related]
8. White blood cell count and abdominal fat distribution in female obese adolescents.
Kim JA; Park HS
Metabolism; 2008 Oct; 57(10):1375-9. PubMed ID: 18803941
[TBL] [Abstract][Full Text] [Related]
9. Clinical and biochemical factors associated with area and metabolic activity in the visceral and subcutaneous adipose tissues by FDG-PET/CT.
Tahara N; Yamagishi S; Kodama N; Tahara A; Honda A; Nitta Y; Igata S; Matsui T; Takeuchi M; Kaida H; Kurata S; Abe T; Fukumoto Y
J Clin Endocrinol Metab; 2015 May; 100(5):E739-47. PubMed ID: 25695885
[TBL] [Abstract][Full Text] [Related]
10. Aerobic exercise training reduces epicardial fat in obese men.
Kim MK; Tomita T; Kim MJ; Sasai H; Maeda S; Tanaka K
J Appl Physiol (1985); 2009 Jan; 106(1):5-11. PubMed ID: 18927266
[TBL] [Abstract][Full Text] [Related]
11. Association of decrease in carbohydrate intake with reduction in abdominal fat during 3-month moderate low-carbohydrate diet among non-obese Japanese patients with type 2 diabetes.
Sasakabe T; Haimoto H; Umegaki H; Wakai K
Metabolism; 2015 May; 64(5):618-25. PubMed ID: 25682064
[TBL] [Abstract][Full Text] [Related]
12. Abdominal visceral fat accumulation measured by computed tomography associated with an increased risk of gallstone disease.
Sekine K; Nagata N; Sakamoto K; Arai T; Shimbo T; Shinozaki M; Okubo H; Watanabe K; Imbe K; Mikami S; Nozaki Y; Sakurai T; Yokoi C; Kojima Y; Kobayakawa M; Yanase M; Akiyama J; Noda M; Uemura N
J Gastroenterol Hepatol; 2015 Aug; 30(8):1325-31. PubMed ID: 25869941
[TBL] [Abstract][Full Text] [Related]
13. Orlistat maintains biliary lipid composition and hepatobiliary function in obese subjects undergoing moderate weight loss.
Trouillot TE; Pace DG; McKinley C; Cockey L; Zhi J; Häeussler J; Guerciolini R; Showalter R; Everson GT
Am J Gastroenterol; 2001 Jun; 96(6):1888-94. PubMed ID: 11421247
[TBL] [Abstract][Full Text] [Related]
14. Associations between breast adipose tissue, body fat distribution and cardiometabolic risk in women: cross-sectional data and weight-loss intervention.
Schautz B; Later W; Heller M; Müller MJ; Bosy-Westphal A
Eur J Clin Nutr; 2011 Jul; 65(7):784-90. PubMed ID: 21427743
[TBL] [Abstract][Full Text] [Related]
15. The effects of orlistat on weight and on serum lipids in obese patients with hypercholesterolemia: a randomized, double-blind, placebo-controlled, multicentre study.
Muls E; Kolanowski J; Scheen A; Van Gaal L;
Int J Obes Relat Metab Disord; 2001 Nov; 25(11):1713-21. PubMed ID: 11753595
[TBL] [Abstract][Full Text] [Related]
16. Effects of pioglitazone on visceral fat metabolic activity in impaired glucose tolerance or type 2 diabetes mellitus.
Kodama N; Tahara N; Tahara A; Honda A; Nitta Y; Mizoguchi M; Kaida H; Ishibashi M; Abe T; Ikeda H; Narula J; Fukumoto Y; Yamagishi S; Imaizumi T
J Clin Endocrinol Metab; 2013 Nov; 98(11):4438-45. PubMed ID: 24030946
[TBL] [Abstract][Full Text] [Related]
17. Effect of rimonabant on the high-triglyceride/ low-HDL-cholesterol dyslipidemia, intraabdominal adiposity, and liver fat: the ADAGIO-Lipids trial.
Després JP; Ross R; Boka G; Alméras N; Lemieux I;
Arterioscler Thromb Vasc Biol; 2009 Mar; 29(3):416-23. PubMed ID: 19112166
[TBL] [Abstract][Full Text] [Related]
18. Adipose tissue attenuation as a marker of adipose tissue quality: Associations with six-year changes in body weight.
Therkelsen KE; Pedley A; Rosenquist KJ; Hoffmann U; Massaro JM; Murabito JM; Fox CS
Obesity (Silver Spring); 2016 Feb; 24(2):499-505. PubMed ID: 26694629
[TBL] [Abstract][Full Text] [Related]
19. The human visceral fat depot has a unique inflammatory profile.
Alvehus M; Burén J; Sjöström M; Goedecke J; Olsson T
Obesity (Silver Spring); 2010 May; 18(5):879-83. PubMed ID: 20186138
[TBL] [Abstract][Full Text] [Related]
20. Relationships between computed tomography-assessed density, abdominal fat volume, and glucose metabolism after sleeve gastrectomy in Japanese patients with obesity.
Ozeki Y; Masaki T; Yoshida Y; Okamoto M; Anai M; Gotoh K; Endo Y; Ohta M; Inomata M; Shibata H
Endocr J; 2019 Jul; 66(7):605-613. PubMed ID: 31019152
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
